Company intelligence / Profile preview

Endolith

Westminster, Colorado, United Statesendolithmining.com ↗

Ownership: Private
Development stage: Commercial

Overview

Endolith has demonstrated that its proprietary, bioengineered microbes can significantly improve copper recoveries from low-grade sulfide ores under simulated field conditions. Its process outperformed conventional heap-leaching methods, unlocking value from previously uneconomic mineralized waste. The system uses a three-phase biohydrometallurgical process—microbial diagnostics, on-site biohatcheries, and cloud-based monitoring—to maximize efficiency while reducing environmental impact. The company is expanding its approach to lithium and rare earth element recovery.

Modalities: Microbial therapy (industrial application)Synthetic biology platform
Industry: Non-Drug Biotech

Partnerships

BHP Think & Act Differently innovation program ("TAD")Unearthed mining accelerator

Beyond the preview

Go deeper on Endolith.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endolith.

Explore the full profile